PLASMASELECT

Welcome to the Brand page for “PLASMASELECT”, which is offered here for In the statement, column 2, line 4, between patient, and valves, canulas should be inserted.;pharmaceutical preparations for the treatment of diabetic food syndrome, microcirculatory disorders in connection with diabetes, retinopathy, polyneuropathy, apoplexy, sudden deafness, sepsis, arterial occlusive diseases or impaired kidney function; pharmaceutical preparations, biochemical and immunological products for use in extracorporeal plasma therapy; pharmaceutical preparations, adsorbers for use in extracorporeal plasma therapy, peptide adsorbers;plasma select;medical devices and apparatus for extracorporeal plasma therapy, comprising a plasma separation unit, a control unit for controlling the plasma separation unit, pumps, hosing systems for delivering blood from the patient to the device and for return to the patient, * canulas, * valves, filter systems, sterile filters, ph or optical detectors and flow controllers, as well as parts and accessories thereof; chromatography columns, in particular adsorption columns and cartridges for use in extracorporeal plasma therapy; plasma separation devices and apparatus, comprising a plasma separation unit and parts and accessories therefor;.

Its status is currently believed to be active. Its class is unavailable. “PLASMASELECT” is believed to be currently owned by “PLASMASELECT AKTIENGESELLSCHAFT”.